Berlin - Delayed Quote EUR
Adaptimmune Therapeutics PLC (473A.BE)
0.2400
-0.0020
(-0.83%)
At close: May 30 at 5:20:06 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-107,848
-73,206
-140,880
-141,769
10,729
Investing Cash Flow
-17,440
-58,952
176,538
89,137
75,800
Financing Cash Flow
24,194
78,749
880
12,867
3,288
End Cash Position
42,434
93,206
147,017
109,602
151,666
Income Tax Paid Supplemental Data
--
1,525
4,000
630
535
Interest Paid Supplemental Data
--
2,092
0
0
--
Capital Expenditure
-3,565
-2,720
-4,880
-29,740
-8,781
Issuance of Capital Stock
133
29,172
624
12,817
2,529
Issuance of Debt
--
49,500
0
0
--
Free Cash Flow
-111,413
-75,926
-145,760
-171,509
1,948
12/31/2021 - 4/13/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade